Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
researcher who is passionate about developing automated systems for microbiological research. The ideal candidate has: An MSc degree in bioengineering, biotechnology, microbiology, computer science, mechanical
-
the genetic etiology and developing diagnostics and treatment methods for these diseases. Approaches range from human genetics, genomics, protein biochemistry and neuronal and glial cell biology to integrative
-
fundamental research and a strong emphasis on innovation and business development. VIB is deeply committed to driving the growth of the thriving life sciences cluster in Flanders. The VIB Technologies program
-
to develop new carbon capture technologies. We are seeking a motivated postdoc to identify biochemical activities in phytoplankton that convert intracellular metabolites into stable, degradation-resistant
-
, an excellence-based research institute KU Leuven, one of Europe’s leading research universities State-of-the-art research facilities An extensive VIB and KU Leuven training program to broaden your
-
and Bash, Python, PowerShell scripting. Identify trends and problems and plan changes to improve stability and optimize performance. Create and maintain documentation, knowledge articles and processes
-
and supportive international research environment (with English as main language) State-of-the-art infrastructure A varied work schedule, with significant autonomy over how you plan your day An
-
in A. thaliana and wheat, which we started to functionally characterize. The Vascular Development group (https://www.derybellab.be), studies plant vascular development at the interface between
-
that underlies cancer initiation, progression and metastatic dissemination with the ultimate goal to develop more effective and specific anti-cancer (combination) therapies. CCB is currently composed
-
of the biology that underlies cancer initiation, progression and metastatic dissemination with the ultimate goal to develop more effective and specific anti-cancer (combination) therapies. CCB is currently